• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CAF 来源的中期因子通过上调胃癌中的长链非编码 RNA ST7-AS1 促进 EMT 和顺铂耐药。

CAF-derived midkine promotes EMT and cisplatin resistance by upregulating lncRNA ST7-AS1 in gastric cancer.

机构信息

Department of Pathology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan Province, People's Republic of China.

Department of Gynecology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan Province, People's Republic of China.

出版信息

Mol Cell Biochem. 2022 Nov;477(11):2493-2505. doi: 10.1007/s11010-022-04436-x. Epub 2022 May 19.

DOI:10.1007/s11010-022-04436-x
PMID:35588343
Abstract

This study aimed to investigate the role of cancer-associated fibroblast (CAF)-derived midkine (MK) in cisplatin (DDP) resistance. The primary cultures of CAFs and non-cancer fibroblasts (NFs) were isolated and purified. The DDP-resistant gastric cancer (GC) cells were cultured with CAF-conditioned medium. QRT-PCR and Elisa assays were employed to determine MK expression. The expression of ST7-AS1 was measured by qRT-PCR. The impact of CAFs, MK, and ST7-AS1 silencing on DDP resistance was determined by MTT and Annexin V/PI staining assay. Expression of EMT markers and PI3K/AKT was determined by Western blot and qRT-PCR. The role of MK in DDP resistance was confirmed in a xenograft model. Incubation with CAF-conditioned medium increased the IC50 to DDP. Also, incubation with CAF-conditioned medium increased cell viability, reduced cell apoptosis, and promoted EMT in DDP-resistant GC cells, which were all blocked with MK neutralization antibody treatment. MK increased the DDP resistance and upregulated the expression of ST7-AS1 in DDP-resistant GC cells. Additionally, ST7-AS1 knockdown increased the sensitivity to DDP by inhibiting EMT. Moreover, ST7-AS1 knockdown significantly decreased the phosphorylation of PI3K and AKT, and suppressed EMT, which were restored by MK addition. Finally, MK promoted tumor growth and DDP resistance in a mice model bearing the SGC-7901/DDP xenografts. CAF-derived MK promotes EMT-mediated DDP resistance via upregulation of ST7-AS1 and activation of PI3K/AKT pathway.

摘要

本研究旨在探讨癌相关成纤维细胞(CAF)衍生的中期因子(MK)在顺铂(DDP)耐药中的作用。原代培养 CAF 和非癌成纤维细胞(NF)并进行分离和纯化。用 CAF 条件培养基培养 DDP 耐药胃癌(GC)细胞。采用 QRT-PCR 和 Elisa 检测 MK 表达。采用 qRT-PCR 检测 ST7-AS1 的表达。通过 MTT 和 Annexin V/PI 染色实验确定 CAFs、MK 和 ST7-AS1 沉默对 DDP 耐药的影响。通过 Western blot 和 qRT-PCR 检测 EMT 标志物和 PI3K/AKT 的表达。MK 在 DDP 耐药中的作用在异种移植模型中得到了验证。用 CAF 条件培养基孵育增加了 DDP 的 IC50。此外,用 CAF 条件培养基孵育增加了 DDP 耐药 GC 细胞的活力,减少了细胞凋亡,促进了 EMT,而用 MK 中和抗体处理则阻断了这一作用。MK 增加了 DDP 耐药性,并上调了 DDP 耐药 GC 细胞中 ST7-AS1 的表达。此外,ST7-AS1 敲低通过抑制 EMT 增加了对 DDP 的敏感性。此外,ST7-AS1 敲低显著降低了 PI3K 和 AKT 的磷酸化,并抑制了 EMT,而 MK 的加入则恢复了这些作用。最后,MK 在 SGC-7901/DDP 异种移植瘤荷瘤小鼠模型中促进了肿瘤生长和 DDP 耐药。CAF 衍生的 MK 通过上调 ST7-AS1 和激活 PI3K/AKT 通路促进 EMT 介导的 DDP 耐药。

相似文献

1
CAF-derived midkine promotes EMT and cisplatin resistance by upregulating lncRNA ST7-AS1 in gastric cancer.CAF 来源的中期因子通过上调胃癌中的长链非编码 RNA ST7-AS1 促进 EMT 和顺铂耐药。
Mol Cell Biochem. 2022 Nov;477(11):2493-2505. doi: 10.1007/s11010-022-04436-x. Epub 2022 May 19.
2
Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.长链非编码RNA XLOC_006753通过PI3K/AKT/mTOR信号通路促进胃癌细胞多药耐药性的发展。
Cell Physiol Biochem. 2018;51(3):1221-1236. doi: 10.1159/000495499. Epub 2018 Nov 27.
3
LncRNA SNHG6 knockdown inhibits cisplatin resistance and progression of gastric cancer through miR-1297/BCL-2 axis.长链非编码 RNA SNHG6 敲低通过 miR-1297/BCL-2 轴抑制顺铂耐药和胃癌进展。
Biosci Rep. 2021 Dec 22;41(12). doi: 10.1042/BSR20211885.
4
FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway.FOXD1-AS1 通过激活 PI3K/AKT/mTOR 通路调节 FOXD1 翻译,促进胃癌的进展和化疗耐药性。
Mol Oncol. 2021 Jan;15(1):299-316. doi: 10.1002/1878-0261.12728. Epub 2020 Nov 14.
5
Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.敲低长链非编码 RNA HOTAIR 通过上调 miR-34a 抑制 PI3K/Akt 和 Wnt/β-catenin 信号通路抑制胃癌细胞顺铂耐药。
Int J Biol Macromol. 2018 Feb;107(Pt B):2620-2629. doi: 10.1016/j.ijbiomac.2017.10.154. Epub 2017 Oct 26.
6
miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.miR-21 通过抑制自噬来调节胃癌细胞对顺铂的耐药性,其作用机制是通过 PI3K/Akt/mTOR 通路。
Anticancer Drugs. 2020 Apr;31(4):385-393. doi: 10.1097/CAD.0000000000000886.
7
HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2.HOXD-AS1 通过招募 EZH2 表观遗传沉默 PDCD4 赋予胃癌顺铂耐药性。
Open Biol. 2019 Sep 27;9(9):190068. doi: 10.1098/rsob.190068. Epub 2019 Sep 25.
8
MicroRNA-95-3p serves as a contributor to cisplatin resistance in human gastric cancer cells by targeting EMP1/PI3K/AKT signaling.MicroRNA-95-3p 通过靶向 EMP1/PI3K/AKT 信号通路促进人胃癌细胞对顺铂耐药。
Aging (Albany NY). 2021 Mar 10;13(6):8665-8687. doi: 10.18632/aging.202679.
9
Midkine derived from cancer-associated fibroblasts promotes cisplatin-resistance via up-regulation of the expression of lncRNA ANRIL in tumour cells.源自癌症相关成纤维细胞的中期因子通过上调肿瘤细胞中长链非编码 RNA ANRIL 的表达促进顺铂耐药性。
Sci Rep. 2017 Nov 24;7(1):16231. doi: 10.1038/s41598-017-13431-y.
10
Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.下调的长链非编码 RNA MSC-AS1 通过与 microRNA-142 结合抑制骨肉瘤进展并增加顺铂敏感性
Med Sci Monit. 2020 Mar 10;26:e921594. doi: 10.12659/MSM.921594.

引用本文的文献

1
Midkine Promotes Tumor Growth and Attenuates the Effect of Cisplatin in Small Cell Lung Cancer.中期因子促进小细胞肺癌的肿瘤生长并减弱顺铂的作用。
Cancer Med. 2025 Jul;14(13):e71034. doi: 10.1002/cam4.71034.
2
Multi-Transcriptomic Analysis Reveals GSC-Driven MES-Like Differentiation via EMT in GBM Cell-Cell Communication.多转录组分析揭示了胶质母细胞瘤细胞间通讯中通过上皮-间质转化由胶质瘤干细胞驱动的间充质样分化。
Biomedicines. 2025 May 26;13(6):1304. doi: 10.3390/biomedicines13061304.
3
Notable influences of estrogen and sex-specific microenvironment in colorectal cancer revealed by single-cell transcriptome analysis.

本文引用的文献

1
Midkine promotes glioblastoma progression via PI3K-Akt signaling.中期因子通过PI3K-Akt信号通路促进胶质母细胞瘤进展。
Cancer Cell Int. 2021 Sep 23;21(1):509. doi: 10.1186/s12935-021-02212-3.
2
Long non-coding RNA maternally expressed gene 3 affects cell proliferation, apoptosis and migration by targeting the microRNA-9-5p/midkine axis and activating the phosphoinositide-dependent kinase/AKT pathway in hepatocellular carcinoma.长链非编码RNA母系表达基因3通过靶向微小RNA-9-5p/中期因子轴并激活磷脂酰肌醇依赖性激酶/AKT途径影响肝癌细胞的增殖、凋亡和迁移。
Oncol Lett. 2021 May;21(5):345. doi: 10.3892/ol.2021.12606. Epub 2021 Mar 3.
3
单细胞转录组分析揭示雌激素和性别特异性微环境在结直肠癌中的显著影响。
Int J Med Sci. 2025 May 28;22(11):2637-2652. doi: 10.7150/ijms.106133. eCollection 2025.
4
Midkine (MDK) in cancer and drug resistance: from inflammation to therapy.癌症与耐药性中的中期因子(MDK):从炎症到治疗
Discov Oncol. 2025 Jun 11;16(1):1062. doi: 10.1007/s12672-025-02941-1.
5
Significance of Midkine Signaling in Women's Cancers: Novel Biomarker and Therapeutic Target.中期因子信号通路在女性癌症中的意义:新型生物标志物与治疗靶点
Int J Mol Sci. 2025 May 17;26(10):4809. doi: 10.3390/ijms26104809.
6
LncRNA in gastric cancer drug resistance: deciphering the therapeutic strategies.长链非编码RNA在胃癌耐药中的作用:解析治疗策略
Front Oncol. 2025 Apr 1;15:1552773. doi: 10.3389/fonc.2025.1552773. eCollection 2025.
7
A narrative review of papillary thyroid carcinoma-related long non-coding RNAs and their relevance to malignant tumors.甲状腺乳头状癌相关长链非编码RNA及其与恶性肿瘤相关性的叙述性综述
Transl Cancer Res. 2025 Mar 30;14(3):2125-2149. doi: 10.21037/tcr-24-1038. Epub 2025 Mar 27.
8
Long non-coding RNAs are involved in the crosstalk between cancer-associated fibroblasts and tumor cells.长链非编码RNA参与癌症相关成纤维细胞与肿瘤细胞之间的相互作用。
Front Immunol. 2024 Dec 9;15:1469918. doi: 10.3389/fimmu.2024.1469918. eCollection 2024.
9
Research on Correlations of lncRNA ST7-AS1 with Progression and Therapeutic Targets of Esophageal Cancer.lncRNA ST7-AS1与食管癌进展及治疗靶点的相关性研究
Turk J Gastroenterol. 2024 Dec 16;36(2):82-88. doi: 10.5152/tjg.2024.24260.
10
Unveiling the contribution of tumor-associated macrophages in driving epithelial-mesenchymal transition: a review of mechanisms and therapeutic Strategies.揭示肿瘤相关巨噬细胞在驱动上皮-间质转化中的作用:机制与治疗策略综述
Front Pharmacol. 2024 Sep 2;15:1404687. doi: 10.3389/fphar.2024.1404687. eCollection 2024.
LncRNA ST7-AS1, by regulating miR-181b-5p/KPNA4 axis, promotes the malignancy of lung adenocarcinoma.
长链非编码RNA ST7-AS1通过调控miR-181b-5p/KPNA4轴促进肺腺癌的恶性进展。
Cancer Cell Int. 2020 Dec 17;20(1):568. doi: 10.1186/s12935-020-01652-7.
4
LncRNA regulation: New frontiers in epigenetic solutions to drug chemoresistance.长链非编码 RNA 调控:药物化疗耐药性的表观遗传解决方案的新前沿。
Biochem Pharmacol. 2021 Jul;189:114228. doi: 10.1016/j.bcp.2020.114228. Epub 2020 Sep 23.
5
Knockdown of ST7-AS1 inhibits migration, invasion, cell cycle progression and induces apoptosis of gastric cancer.ST7反义RNA1的敲低抑制胃癌的迁移、侵袭、细胞周期进程并诱导其凋亡。
Oncol Lett. 2020 Jan;19(1):777-782. doi: 10.3892/ol.2019.11145. Epub 2019 Nov 25.
6
Emerging roles of lncRNA in cancer and therapeutic opportunities.长链非编码RNA在癌症中的新作用及治疗机会
Am J Cancer Res. 2019 Jul 1;9(7):1354-1366. eCollection 2019.
7
Role of Cancer-Associated Fibroblast in Gastric Cancer Progression and Resistance to Treatments.癌症相关成纤维细胞在胃癌进展及治疗抵抗中的作用
J Oncol. 2019 Jun 9;2019:6270784. doi: 10.1155/2019/6270784. eCollection 2019.
8
The long noncoding RNA ST7-AS1 promotes laryngeal squamous cell carcinoma by stabilizing CARM1.长链非编码 RNA ST7-AS1 通过稳定 CARM1 促进喉鳞状细胞癌。
Biochem Biophys Res Commun. 2019 Apr 23;512(1):34-40. doi: 10.1016/j.bbrc.2019.02.057. Epub 2019 Mar 7.
9
CD44 Facilitates Epithelial-to-Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung Cancer.CD44 促进肺癌获得 EGFR 激酶抑制剂耐药时上皮间质转化表型改变。
Mol Cancer Ther. 2018 Oct;17(10):2257-2265. doi: 10.1158/1535-7163.MCT-17-1279. Epub 2018 Jul 26.
10
Gastric cancer: epidemiology, prevention, classification, and treatment.胃癌:流行病学、预防、分类及治疗
Cancer Manag Res. 2018 Feb 7;10:239-248. doi: 10.2147/CMAR.S149619. eCollection 2018.